NEXT GENERATION OF HARMONIZED SYSTEMS, COMBINED WITH RECENTLY LAUNCHED ALINIQ PROFESSIONAL SERVICES, PROVIDE A UNIQUE SOLUTION TO HELP LABS AND HOSPITAL SYSTEMS ACHIEVE MEASURABLY BETTER HEALTHCARE ...
Alinity, a family of next-generation clinical chemistry and immunoassay diagnostics from Abbott Laboratories (NYSE:ABT) is now being offered in Europe and other countries that distinguish the CE mark.
ABBOTT PARK, Ill., March 5, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that Regional Medical Laboratory, Inc. (RML) will use the company's most advanced technology, Alinity ci-series, to ...
* Abbott laboratories - secured U.S. FDA 510 clearance for its alinity ci-series instruments for clinical chemistry and immunoassay diagnostics Source text for Eikon: Further company coverage: Sign ...
"Better healthcare begins with a high performing lab. Abbott's Alinity family is an unprecedented approach to providing a more efficient, complete lab solution that no competitor in the industry can ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback